High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?
about
Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α (PGC-1α) Regulates the Expression of B-Cell Lymphoma/Leukemia-2 (Bcl-2) and Promotes the Survival of Mesenchymal Stem Cells (MSCs) via PGC-1α/ERRα Interaction in the Absence of Serum, HypoxRadioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma
P2860
High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
High dose therapy and autologo ...... sible, but for which patients?
@ast
High dose therapy and autologo ...... sible, but for which patients?
@en
High dose therapy and autologo ...... sible, but for which patients?
@nl
type
label
High dose therapy and autologo ...... sible, but for which patients?
@ast
High dose therapy and autologo ...... sible, but for which patients?
@en
High dose therapy and autologo ...... sible, but for which patients?
@nl
prefLabel
High dose therapy and autologo ...... sible, but for which patients?
@ast
High dose therapy and autologo ...... sible, but for which patients?
@en
High dose therapy and autologo ...... sible, but for which patients?
@nl
P2860
P1476
High dose therapy and autologo ...... sible, but for which patients?
@en
P2093
Amanda Cashen
P2860
P304
P356
10.1016/J.JGO.2015.07.001
P407
P577
2015-08-10T00:00:00Z